PB2203: INCIDENCE AND PREVALENCE OF MYELOFIBROSIS IN GERMANY: A RETROSPECTIVE CLAIMS DATA ANALYSIS

• Sophia Junker,
• Alexander Slowley,
• Joachim Göthert,
• Tim D’estrube,
• Kelesitse Phiri,
• Martin Krammer,
• Lena Sofie Weinmann,
• Florian Karl,
• Suzanne Landi,
• Sabrina Müller,
• Boris Gorsh

Affiliations

Sophia Junker

1 Cytel Inc., Berlin, Germany

Alexander Slowley

2 GSK plc, London, United Kingdom

Joachim Göthert

3 Essen University Hospital Department of Hematology, Essen, Germany

Tim D’estrube

2 GSK plc, London, United Kingdom

Kelesitse Phiri

4 GSK plc, Philadelphia, United States

Martin Krammer

5 GSK plc, Munich, Germany

Lena Sofie Weinmann

5 GSK plc, Munich, Germany

Florian Karl

5 GSK plc, Munich, Germany

Suzanne Landi

6 Pfizer Inc., New York, United States

Sabrina Müller

7 Institut für Pharmakoökonomie und Arzneimittellogistik, Wismar, Germany

Boris Gorsh

4 GSK plc, Philadelphia, United States